Send mail to Author

An open-label trial of 12-week Simeprevir plus Peginterferon/Ribavirin (PR) in treatment-naïve patients with hepatitis C Virus (HCV) genotype 1 (GT1) (Article)

Please indicate your contact information and select, which author you want to contact.



 
   _____     ___      _____    _    _     ______    ______  
  / ___//   / _ \\   / ____|| | || | ||  /_____//  /_   _// 
  \___ \\  | / \ || / //---`' | || | ||  `____ `    -| ||-  
  /    //  | \_/ || \ \\___   | \\_/ ||  /___//     _| ||_  
 /____//    \___//   \_____||  \____//   `__ `     /_____// 
`-----`     `---`     `----`    `---`    /_//      `-----`  
                                         `-`
 


Back to frontdoor view

OPUS4 Logo